Cargando…

Prolonged Pediatric Extracorporeal Membrane Oxygenation Support with Cardiopulmonary Failure in Juvenile Myelomonocytic Leukemia

We report a case of a child survival after extracorporeal membrane oxygenation (ECMO) support of 25 days for cardiopulmonary failure and septic shock in the context of juvenile myelomonocytic leukemia (JMML). ECMO support is still a matter of debate for the management of septic patients with maligna...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartkevics, Maris, Hennig, Bert, Gungor, Tayfun, Ammann, Roland, Kadner, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201439/ https://www.ncbi.nlm.nih.gov/pubmed/32509361 http://dx.doi.org/10.1155/2020/5696380

Ejemplares similares

The Genomic Landscape of Juvenile Myelomonocytic Leukemia
por: Stieglitz, Elliot, et al.
Publicado: (2015)

Current Treatment of Juvenile Myelomonocytic Leukemia
por: Mayerhofer, Christina, et al.
Publicado: (2021)

Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia
por: Liu, Xiaoling, et al.
Publicado: (2012)

Genomic and Epigenomic Landscape of Juvenile Myelomonocytic Leukemia
por: Fiñana, Claudia, et al.
Publicado: (2022)

Novel splicing-factor mutations in juvenile myelomonocytic leukemia
por: Takita, J, et al.
Publicado: (2012)

Molecular and phenotypic diversity of CBLmutated juvenile myelomonocytic leukemia
por: Hecht, Anna, et al.
Publicado: (2020)

P1072: NATURAL HISTORY OF JUVENILE MYELOMONOCYTIC LEUKEMIA
por: Yang, W., et al.
Publicado: (2022)

Single-Center Experience With Epigenetic Treatment for Juvenile Myelomonocytic Leukemia
por: Marcu, Andra, et al.
Publicado: (2020)

Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia
por: Louka, Eleni, et al.
Publicado: (2021)

Clinical and molecular features of CBL-mutated juvenile myelomonocytic leukemia
por: Yoshida, Taro, et al.
Publicado: (2023)

Pediatric extracorporeal cardiopulmonary resuscitation: single-center study
por: KENDİRLİ, Tanıl, et al.
Publicado: (2021)

CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia
por: Fluhr, Silvia, et al.
Publicado: (2016)

Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia
por: Stieglitz, Elliot, et al.
Publicado: (2017)

Gene module analysis of juvenile myelomonocytic leukemia and screening of anticancer drugs
por: Zhao, Wencheng, et al.
Publicado: (2018)

Deficiency of CREB and over expression of miR-183 in juvenile myelomonocytic leukemia
por: Liu, Y L, et al.
Publicado: (2013)

Management of Two Juvenile Myelomonocytic Leukemia Patients According to Clinical and Genetic Features
por: Tüfekçi, Özlem, et al.
Publicado: (2015)

Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia
por: Sakaguchi, Hirotoshi, et al.
Publicado: (2015)

Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia
por: Niemeyer, Charlotte M., et al.
Publicado: (2010)

Juvenile Myelomonocytic Leukemia in Turkey: A Retrospective Analysis of Sixty-five Patients
por: Tüfekçi, Özlem, et al.
Publicado: (2018)

RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
por: Lipka, Daniel B., et al.
Publicado: (2017)

Use of Rapamycin in a Patient With Juvenile Myelomonocytic Leukemia: A Case Report
por: Upadhyay, Shivani Y., et al.
Publicado: (2017)

Parvovirus B19 Infection Mimicking Juvenile Myelomonocytic Leukemia in an Immunocompetent Child
por: Mathew, Aji, et al.
Publicado: (2020)

Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia
por: Hofmans, Mattias, et al.
Publicado: (2021)

Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia
por: Kitazawa, Hironobu, et al.
Publicado: (2021)

P985: CLL-1 IS AN ADOPTIVE IMMUNOTHERAPY TARGET IN JUVENILE MYELOMONOCYTIC LEUKEMIA
por: Huebner, Juwita, et al.
Publicado: (2023)

CircRNAs Dysregulated in Juvenile Myelomonocytic Leukemia: CircMCTP1 Stands Out
por: Dal Molin, Anna, et al.
Publicado: (2021)

Exploring the genetic and epigenetic origins of juvenile myelomonocytic leukemia using newborn screening samples
por: Behnert, Astrid, et al.
Publicado: (2021)

Leukemia cutis in a child with juvenile myelomonocytic leukemia presenting with Sweet syndrome–like lesions and a history of multiple juvenile xanthogranulomas
por: Quek, Chrystie Wan Ning, et al.
Publicado: (2020)

A Pediatric Case of Systemic Lupus Erythematosus Developed 10 Years after Cord Blood Transplantation for Juvenile Myelomonocytic Leukemia
por: Nagasawa, Masayuki, et al.
Publicado: (2012)

Outcome Predictors of Pediatric Extracorporeal Cardiopulmonary Resuscitation
por: Kelly, Robert B., et al.
Publicado: (2010)

Juvenile Myelomonocytic Leukemia: Molecular Pathogenesis Informs Current Approaches to Therapy and Hematopoietic Cell Transplantation
por: Dvorak, Christopher C., et al.
Publicado: (2014)

Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia
por: Hasegawa, D, et al.
Publicado: (2013)

Induced Pluripotent Stem Cells to Model Juvenile Myelomonocytic Leukemia: New Perspectives for Preclinical Research
por: Wehbe, Zeinab, et al.
Publicado: (2021)

Juvenile myelomonocytic leukemia in the molecular era: a clinician’s guide to diagnosis, risk stratification, and treatment
por: Wintering, Astrid, et al.
Publicado: (2021)

Cardiopulmonary Failure Requiring ECMO Bypass Resulting from Leukemia Cell Lysis in a Patient with Childhood Acute Myelomonocytic Leukemia
por: Huang, Michael, et al.
Publicado: (2015)

Prognosis in the Patients with Prolonged Extracorporeal Membrane Oxygenation
por: Kim, Tae-Hun, et al.
Publicado: (2012)

Necrotizing pneumonia requiring prolonged extracorporeal membrane oxygenation: Pushing the boundaries in pediatric ECMO
por: R. R., Pravin, et al.
Publicado: (2022)

Newly Developed Pediatric Membrane Oxygenator that Suppresses Excessive Pressure Drop in Cardiopulmonary Bypass and Extracorporeal Membrane Oxygenation (ECMO)
por: Fukuda, Makoto, et al.
Publicado: (2020)

Cytosine Arabinoside and Mitoxantrone Followed by Second Allogeneic Transplant for the Treatment of Children With Refractory Juvenile Myelomonocytic Leukemia
por: Patel, Sachit A., et al.
Publicado: (2014)

Allogeneic bone marrow transplantation for juvenile myelomonocytic leukemia: a single center experience of 23 patients
por: Korthof, E T, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_9v856fhjd0j44vfgl6rffasqj3